APA (7th ed.) Citation

M, H., L, K., PA, C., C, C., G, G., SL, G., . . . MA, P. (2009). The efficacy of natalizumab in patients with relapsing multiple sclerosis: Subgroup analyses of AFFIRM and SENTINEL. Journal of neurology, 256(3), 405. https://doi.org/10.1007/s00415-009-0093-1

Chicago Style (17th ed.) Citation

M, Hutchinson, et al. "The Efficacy of Natalizumab in Patients with Relapsing Multiple Sclerosis: Subgroup Analyses of AFFIRM and SENTINEL." Journal of Neurology 256, no. 3 (2009): 405. https://doi.org/10.1007/s00415-009-0093-1.

MLA (9th ed.) Citation

M, Hutchinson, et al. "The Efficacy of Natalizumab in Patients with Relapsing Multiple Sclerosis: Subgroup Analyses of AFFIRM and SENTINEL." Journal of Neurology, vol. 256, no. 3, 2009, p. 405, https://doi.org/10.1007/s00415-009-0093-1.